Case study

British Columbia Cancer Research Centre (BCCRC) & biomodal

The Aparicio lab at the British Columbia Cancer Research Centre (BCCRC) utilises 5-letter sequencing technology, duet multiomics solution +modC, to investigate ‘epigenetic rewiring’ in breast cancer cells.

Poster

Simultaneous measurement of genetics and epigenetics enables new biological insight

Learn how simultaneous measurement of genetics and epigenetics with duet multiomics solution +modC enables the study of allele-specific methylation and how this can be used to understand the impact of epigenetic rejuvenation.

Poster

High-quality information from FFPE samples: a genetic and epigenetic study of formalin-damaged DNA

Review performance of duet multiomics solution +modC for the detection of genetic and epigenetic sequence data at base resolution when using formalin damaged DNA. Samples include formalin-compromised DNA standards (fcDNA) as well as DNA extracted from formalin-fixed and paraffin-embedded (FFPE) samples of two colorectal cancer (CRC) patients.

News article

biomodal launches solution to simultaneously sequence genetics and epigenetics in one workflow

News article

New beginnings: becoming biomodal

News article

CEGX Team presents at AGBT 2023

Representatives from our R&D team presented 3 posters at the Advances in Genome Biology & Technology General Meeting in Hollywood, Florida.

News article

CEGX Team Published in Nature Biotechnology!

We are extremely proud to announce that our paper ‘Simultaneous sequencing of genetic and epigenetic bases in DNA’ has been published by the journal Nature Biotechnology.